The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma

Abstract Background Ovarian serous cystadenocarcinoma, accounting for about 90% of ovarian cancers, is frequently diagnosed at advanced stages, leading to suboptimal treatment outcomes. Given the malignant nature of the disease, effective biomarkers for accurate prediction and personalized treatment...

Full description

Bibliographic Details
Published in:Journal of Ovarian Research
Main Authors: Hao Qin, Jie Liu, Yi Qu, Yang-Yang Li, Ya-Lan Xu, Yi-Fang Yan
Format: Article
Language:English
Published: BMC 2024-07-01
Subjects:
Intratumoral microbiota
Ovarian serous cystadenocarcinoma
TCGA-OV
Microbial biomarker
Nomogram
Online Access:https://doi.org/10.1186/s13048-024-01464-7

Internet

https://doi.org/10.1186/s13048-024-01464-7

Similar Items